Debiovision Inc.
Records under this name other than patents Debiovision Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Debiovision Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,767,787 | Substance for obtaining highly effective tumor medications as well as a process Formerly held Lapsed on the fee record Ended Aug 3, 2018 · From the USPTO record | Lapsed on the fee record | Ended Aug 3, 2018 | From the USPTO record |
| US 7,611,894 | Anti-idiotype antibodies of the human monoclonal antibody SC-1, and their production and use Lapsed on the fee record Ended Nov 3, 2013 · From the USPTO record | Lapsed on the fee record | Ended Nov 3, 2013 | From the USPTO record |
| US 7,378,247 | Neoplasm-specific polypeptides and their uses Lapsed on the fee record Ended May 27, 2012 · From the USPTO record | Lapsed on the fee record | Ended May 27, 2012 | From the USPTO record |